These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34121560)

  • 21. Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota.
    Huang D; Wang Y; Xu C; Zou M; Ming Y; Luo F; Xu Z; Miao Y; Wang N; Lin Z; Weng Z
    Int J Biol Macromol; 2024 May; 266(Pt 1):131107. PubMed ID: 38527677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
    Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
    J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Chitosan-Based pH-Sensitive Polymeric Micelles Containing Curcumin for Colon-Targeted Drug Delivery.
    Woraphatphadung T; Sajomsang W; Rojanarata T; Ngawhirunpat T; Tonglairoum P; Opanasopit P
    AAPS PharmSciTech; 2018 Apr; 19(3):991-1000. PubMed ID: 29110292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer.
    Han W; Xie B; Li Y; Shi L; Wan J; Chen X; Wang H
    Theranostics; 2019; 9(24):7458-7473. PubMed ID: 31695780
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
    Sareen R; Jain N; Rajkumari A; Dhar KL
    Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan/alginate nanoparticles as a promising carrier of novel curcumin diethyl diglutarate.
    Sorasitthiyanukarn FN; Ratnatilaka Na Bhuket P; Muangnoi C; Rojsitthisak P; Rojsitthisak P
    Int J Biol Macromol; 2019 Jun; 131():1125-1136. PubMed ID: 30902713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally ingestible medication utilizing layered double hydroxide nanoparticles strengthened alginate and hyaluronic acid-based hydrogel bead for bowel disease management.
    Nguyen NT; Nguyen BT; Ho TN; Tran CD; Tran TH; Nguyen HH; Nguyen HP; Huynh NT; Li Y; Phan VHG; Thambi T
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132122. PubMed ID: 38718992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH Sensitive Quercetin Nanoparticles Ameliorate DSS-Induced Colitis in Mice by Colon-Specific Delivery.
    Wang L; Fu R; Meng Y; Liang J; Xue W; Hu H; Meng J; Zhang M
    Mol Nutr Food Res; 2024 Jan; 68(2):e2300051. PubMed ID: 38010348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin Nanocrystal/pH-Responsive Polyelectrolyte Multilayer Core-Shell Nanoparticles for Inflammation-Targeted Alleviation of Ulcerative Colitis.
    Oshi MA; Lee J; Naeem M; Hasan N; Kim J; Kim HJ; Lee EH; Jung Y; Yoo JW
    Biomacromolecules; 2020 Sep; 21(9):3571-3581. PubMed ID: 32701266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral delivery of pectin-chitosan hydrogels entrapping macrophage-targeted curcumin-loaded liposomes for the treatment of ulcerative colitis.
    Wu M; Ping H; Wang K; Ding H; Zhang M; Yang Z; Du Q
    Int J Pharm; 2023 Nov; 647():123510. PubMed ID: 37839497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of ulcerative colitis
    Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
    Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating.
    Shi J; Zhou J; Liu B; Lin K; Xie X; Han X; Sheng Y; Liu Y; He C; Zhou Y; Zhu N; Yang Q; Luo R; Li Y
    J Nanobiotechnology; 2024 Jul; 22(1):437. PubMed ID: 39061092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.
    Gou S; Huang Y; Wan Y; Ma Y; Zhou X; Tong X; Huang J; Kang Y; Pan G; Dai F; Xiao B
    Biomaterials; 2019 Aug; 212():39-54. PubMed ID: 31103945
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel chitosan-citric acid crosslinked beta-cyclodextrin nanocarriers for insoluble drug delivery.
    Karpkird T; Manaprasertsak A; Penkitti A; Sinthuvanich C; Singchuwong T; Leepasert T
    Carbohydr Res; 2020 Dec; 498():108184. PubMed ID: 33189031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
    Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
    Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment.
    Zhang Y; Wang L; Wang ZD; Zhou Q; Zhou X; Zhou T; Guan YX; Liu X
    J Nanobiotechnology; 2023 May; 21(1):145. PubMed ID: 37127609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
    Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.